Clinical Trials Browser

Phase 1/2 × Has announcements × enfortumab vedotin × Clear all

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms, Urologic Neoplasms